Behavioural Addiction and Genetics in Parkinson's Disease
Trial
N/A
Completed
Jan. 24, 2017
Freezing of Gait in Parkinson's Disease
Trial
N/A
Completed
Jan. 23, 2017
Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease
Trial
Phase 4
Terminated
Jan. 23, 2017
Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia
Trial
Phase 2
Completed
Jan. 22, 2017
Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's
Trial
Phase 3
Completed
Jan. 17, 2017
Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation
Trial
N/A
Completed
Jan. 11, 2017
A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions
Trial
Phase 1
Completed
Jan. 5, 2017
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Trial
N/A
Completed
Jan. 5, 2017
Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects.
Trial
Phase 1
Completed
Jan. 5, 2017
Lubiprostone as a Treatment for Constipation in Parkinson's Disease
Trial
N/A
Terminated
Dec. 29, 2016
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
Trial
Phase 1
Completed
Dec. 15, 2016
ALTROPANE® SPECT Imaging in Patients With Parkinson Disease
Trial
Phase 2
Completed
Dec. 15, 2016
Goal-oriented Intervention in Parkinson's Disease
Trial
N/A
Completed
Dec. 13, 2016
Understand FoG in PD: Behavioral Physiology and Clinical Application
Trial
N/A
Unknown
Dec. 7, 2016
Study of Motor Slowing in Parkinson's Disease by a Computerized Mental Chronometry Paradigm
Trial
N/A
Completed
Dec. 4, 2016
Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease
Trial
Phase 1
Completed
Dec. 4, 2016
Study of the Enteric Nervous System Using Colonic Biopsies in Parkinson Patients With LRRK2 Mutation
Trial
N/A
Terminated
Nov. 30, 2016
Haptoglobin and Iron in Parkinson's Disease
Trial
N/A
Completed
Nov. 28, 2016
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
Trial
N/A
Unknown
Nov. 28, 2016